Banegas Banegas J R, Rodríguez Artalejo F, Martín Moreno J M, del Rey Calero J
Departamento de Medicina Preventiva y Salud Pública, Universidad Autónoma de Madrid.
Med Clin (Barc). 1993 Jun 12;101(3):81-6.
The aim of the application of population and individual strategies for the control of cholesterolemia recommended by several commissions of experts in Spain is to obtain marked decreases in mortality by ischemic heart disease. This study is the first to estimate the potential benefits obtained by the application of both strategies in males from 35 to 64 years of age in Spain.
Upon fixing the population dietetic aims for the ingestion of fats and cholesterol, the foreseen decrease in mean serum cholesterol was estimated by predictive equations. For individuals at risk, more ambitious objectives were made in regard to decrease in cholesterolemia. The consequent reduction of coronary death risk was obtained for each strategy comparing the foreseen coronary risks by logistic functions for previous serum cholesterol values and those posterior to the health intervention.
The population decrease of saturated fat to 7-10% of total calories of the diet and of the consumption of cholesterol to 300 mg/day would produce a reduction of serum cholesterol of between 6.5 and 21.4 mg/dl (0.2-0.6 mmol/l) which would represent nearly 200 mg/dl (5.2 mmol/l). This would then produce a decrease in coronary deaths of 5.5 to 17.1%. This population strategy must reach 934 to 2,857 people per death avoided. With the individual strategy, the reduction of 55 mg/dl (1.4 mmol/l) in mean cholesterolemia of subjects with more than 250 mg/dl (mean 7.1 mmol/l) or of 36 mg/dl (0.9 mmol/l) in those with more than 200 mg/dl (mean 6.2 mmol/l) would produce a decrease of population coronary death between 3.3 and 12.5% in the first group, and 5.2 to 20% in the second requiring 237 or 454 subjects in each group, respectively per death avoided. The joint application of both strategies would reduce the risk from 8.4 to 24.5%. This would delay the appearance of 570 to 1,640 coronary deaths each year.
The population strategy for cholesterolemia control provides greater health benefits, within a short term, than those of individual strategy although it must be applied to more subjects per unit of benefit. The joint application of both strategies may produce a modest but appreciable reduction, within a medium term, of coronary death in Spain.
西班牙多个专家委员会推荐的用于控制胆固醇血症的人群和个体策略的应用目标是显著降低缺血性心脏病的死亡率。本研究首次估计了在西班牙35至64岁男性中应用这两种策略所能获得的潜在益处。
在确定人群饮食中脂肪和胆固醇摄入的目标后,通过预测方程估计血清胆固醇均值的预期降低幅度。对于有风险的个体,在降低胆固醇血症方面设定了更具雄心的目标。通过比较基于先前血清胆固醇值的逻辑函数预测的冠状动脉风险与健康干预后的风险,得出每种策略相应的冠状动脉死亡风险降低情况。
将饮食中饱和脂肪减少至总热量的7 - 10%,胆固醇摄入量减少至300毫克/天,将使血清胆固醇降低6.5至21.4毫克/分升(0.2 - 0.6毫摩尔/升),这相当于接近200毫克/分升(5.2毫摩尔/升)的降低幅度。这将使冠状动脉死亡人数减少5.5%至17.1%。这种人群策略每避免一例死亡必须应用于934至2857人。采用个体策略,对于胆固醇水平超过250毫克/分升(平均7.1毫摩尔/升)的受试者,平均胆固醇血症降低55毫克/分升(1.4毫摩尔/升),或对于胆固醇水平超过200毫克/分升(平均6.2毫摩尔/升)的受试者降低36毫克/分升(0.9毫摩尔/升),将使第一组人群冠状动脉死亡减少3.3%至12.5%,第二组减少5.2%至20%,每组每避免一例死亡分别需要237或454名受试者。两种策略联合应用将使风险从8.4%降低至24.5%。这将每年延迟570至1640例冠状动脉死亡的出现。
控制胆固醇血症的人群策略在短期内比个体策略能带来更大的健康益处,尽管每单位益处必须应用于更多的受试者。两种策略联合应用可能在中期使西班牙的冠状动脉死亡有适度但明显的降低。